(3S,7S,25S,28S)-33-Azido-12,25,28-tribenzyl-5,13,20,23,26,29-hexaoxo-4,6,12,19,24,27,30-heptaazatritriacontane-1,3,7-tricarboxylic Acid

ID: ALA5174173

Chembl Id: CHEMBL5174173

PubChem CID: 168271563

Max Phase: Preclinical

Molecular Formula: C50H66N10O12

Molecular Weight: 999.14

Associated Items:

Names and Identifiers

Canonical SMILES:  [N-]=[N+]=NCCCNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CCC(=O)NCCCCCC(=O)N(CCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)Cc1ccccc1

Standard InChI:  InChI=1S/C50H66N10O12/c51-59-54-30-15-29-53-46(66)40(32-35-16-5-1-6-17-35)56-47(67)41(33-36-18-7-2-8-19-36)55-43(62)26-25-42(61)52-28-13-4-11-23-44(63)60(34-37-20-9-3-10-21-37)31-14-12-22-38(48(68)69)57-50(72)58-39(49(70)71)24-27-45(64)65/h1-3,5-10,16-21,38-41H,4,11-15,22-34H2,(H,52,61)(H,53,66)(H,55,62)(H,56,67)(H,64,65)(H,68,69)(H,70,71)(H2,57,58,72)/t38-,39-,40-,41-/m0/s1

Standard InChI Key:  ODVNIPWOIOANKD-MFDNGWNGSA-N

Alternative Forms

  1. Parent:

    ALA5174173

    ---

Associated Targets(Human)

HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FOLH1 Tclin Glutamate carboxypeptidase II (711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
WI-38 VA13 (346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 999.14Molecular Weight (Monoisotopic): 998.4862AlogP: 3.98#Rotatable Bonds: 35
Polar Surface Area: 338.50Molecular Species: ACIDHBA: 10HBD: 9
#RO5 Violations: 2HBA (Lipinski): 22HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: -10.20CX Basic pKa: 4.29CX LogP: 2.44CX LogD: -7.51
Aromatic Rings: 3Heavy Atoms: 72QED Weighted: 0.02Np Likeness Score: -0.27

References

1. Machulkin AE, Shafikov RR, Uspenskaya AA, Petrov SA, Ber AP, Skvortsov DA, Nimenko EA, Zyk NU, Smirnova GB, Pokrovsky VS, Abakumov MA, Saltykova IV, Akhmirov RT, Garanina AS, Polshakov VI, Saveliev OY, Ivanenkov YA, Aladinskaya AV, Finko AV, Yamansarov EU, Krasnovskaya OO, Erofeev AS, Gorelkin PV, Dontsova OA, Beloglazkina EK, Zyk NV, Khazanova ES, Majouga AG..  (2021)  Synthesis and Biological Evaluation of PSMA Ligands with Aromatic Residues and Fluorescent Conjugates Based on Them.,  64  (8.0): [PMID:33822606] [10.1021/acs.jmedchem.0c01935]
2. Machulkin AE, Uspenskaya AA, Zyk NY, Nimenko EA, Ber AP, Petrov SA, Shafikov RR, Skvortsov DA, Smirnova GB, Borisova YA, Pokrovsky VS, Kolmogorov VS, Vaneev AN, Ivanenkov YA, Khudyakov AD, Kovalev SV, Erofeev AS, Gorelkin PV, Beloglazkina EK, Zyk NV, Khazanova ES, Majouga AG..  (2022)  PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation.,  227  [PMID:34717125] [10.1016/j.ejmech.2021.113936]

Source